SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
847It won't make you feel any better, but I'm still down 20% in BioInvent.keokalani'nui-1/12/2007
846Ouch. Been there, done that...nigel bates-1/12/2007
845BioInvent enters collaboration with Genentech to develop and commercialize BioInIcebrg-1/12/2007
844Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement fornigel bates-1/8/2007
843And a little less likely ever to go public ?nigel bates-1/8/2007
842A hot company just got a little hotter.DewDiligence_on_SI-1/8/2007
841Ablynx and Boehringer Ingelheim Sign $265 Million Research and Licensing Agreemenigel bates-1/8/2007
840Raven and Wyeth Partner to Evaluate and Develop Multiple Antibody Products Thursnigel bates-1/4/2007
839Elusys Announces Collaborative Research and License Agreement with Pfizer Thursdnigel bates-1/4/2007
838MorphoSys Presents New RapMAT(TM) Antibody Technology 12/11/2006 at 07:27 AM Germanecki-12/11/2006
837Just in time for Christmas. Thx GSK.kenhott-12/8/2006
836Peptech Realises A$178m on Domantis' GSK Deal Friday December 8, 6:32 am ET nigel bates-12/8/2006
835Damn. GSK buy Domantis - Message 23082786 (I have a few Peptech, mainly for thnigel bates-12/8/2006
834MorphoSys and the Burnham Institute Sign Broad Research Partnership Tuesday Novenigel bates-11/28/2006
833<i>...and from Friday's Peptech annual report -</i> ...Domantisnigel bates-11/6/2006
832Wyeth signs $212 mln deal for drugs from llama DNA LONDON, Nov 6 (Reuters) - Abnigel bates-11/6/2006
831<i>Posted on the Domantis website in October -</i> Domantis is pionnigel bates-11/1/2006
830A drug for many cures Rupali Mukherjee 30 Oct, 2006 0021hrs ISTTIMES NEWS NETWORIcebrg-10/29/2006
829MorphoSys Reports Nine Months 2006 Results Published: 07:30 27.10.2006 GMT+2 /HGermanecki-10/27/2006
828Biotech company ready to lead pack Murray Lyons, The StarPhoenix Published: SatuIcebrg-10/22/2006
827Xencor Completes $45 Million Financing with MedImmune Ventures, Novo Nordisk andnigel bates-10/19/2006
826Nice. I know the guy from whose lab SC-1 originated..... Peter Vollmers. We scaram(o)uche-10/18/2006
825Cambridge Antibody Technology and MSM Protein Technologies Enter Drug Discovery nigel bates-10/17/2006
824Debiopharm and Cambridge Antibody Technology Enter Into an Exclusive Agreement tnigel bates-10/16/2006
823Morphotek Raises $40 Million to Advance Its Antibody Pipeline Thursday October 1nigel bates-10/12/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News